Misplaced Pages

Yuhan

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
South Korean pharmaceutical company
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Yuhan" – news · newspapers · books · scholar · JSTOR (March 2017) (Learn how and when to remove this message)
Yuhan Corporation
Native name주식회사 유한양행
Company typePublic
Traded asKRX: 000100
IndustryPharmaceutical
Founded1926; 98 years ago (1926)
FounderIlhan New
HeadquartersSeoul, South Korea
Key peopleCho Wook-je
(Chairman & CEO)
Websiteeng.yuhan.co.kr
Footnotes / references
Yuhan
Hangul유한양행
Hanja
Revised RomanizationYuhan Yanghaeng
McCune–ReischauerYuhan Yanghaeng

Yuhan Corporation (Korean: 주식회사 유한양행; Hanja: 株式會社 柳韓洋行; RRJusik Hoesa Yuhan Yanghaeng) is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical.

Group families

  • Yuhan-Kimberly
  • Yuhan-Clorox Co., Ltd.
  • Yuhan Chemical, Inc.
  • Yuhan Medica Corporation
  • Janssen Korea, Ltd.
  • Gujarat Themis Biosyn, Ltd.(GTBL)

Products

Yuhan Brands

  • Pharmaceutical
  • Non-Pharm/Medical Care
  • Health Food
  • Dental/Tooth Care
  • Chemical Cosmetic
  • Living Product
  • Animal Pharmaceuticals

Other Brands

See also

References

  1. ^ "Yuhan Annual Report 2019" (PDF). Yuhan Corporation. Archived from the original (PDF) on July 11, 2021. Retrieved July 11, 2021.
  2. Lim, Jeong-yeo (April 7, 2019). "[Eye on Business] Ilhan New, trailblazer in Korean pharma industry". The Korea Herald.
  3. Kim, Si-gyun; Lee, Susan (March 10, 2022). "Korean pharmas, biotech firms poised to reap over $816 mn revenue in 2022". Maeil Business Newspaper.

External links

KOSPI 200 companies of South Korea
Categories: